Status quo in retail pharmacy won’t suffice
In many significant ways, the chain drug store business looks very different at the start of 2016 than it did a year ago.
Opinion
Hopes of chain drug industry rest with new leaders
Christmas is over, yesterday’s news. And the mass retailing community is scampering to assess its impact on sales, earnings and the future. For chain drug retailers, this holiday selling season, like so many before it, was acceptable, if hardly record-setting.
Health information now captured by what you wear
Putting patients increasingly in control of their well-being and health care outcomes has truly come of age.
Mexican Rx market offers strong growth opportunities
one with outstanding growth potential for pharmacies that build strong differentiating capabilities. The Mexican pharmaceutical market grew 3% annually over the past few years to reach $14
MTM runs into roadblocks
It is said that patience is a virtue. With respect to medication therapy management (MTM) by chain pharmacists, patience has been more a necessity than a virtue. Among and between health care providers, including pharmacists, there have been MTM pilot projects and some test collaborations.
Paradigm shift in mass retailing now under way
The retailing business in the United States may have reached an inflection point during the period around Black Friday, traditionally seen as the start of the holiday selling season.
Questions abound as ’15 draws to a close
and very little was as it had been a year ago. Many of the same familiar faces were on hand, and several of the same retail companies attended. But the yearlong series of events that have
Health care turmoil creates opportunity for Rx
More than five years after enactment of the Affordable Care Act, a measure designed to extend coverage to the uninsured and control expenditures, the turmoil in the U.S. health care system shows no signs of abating.
It’s time for drug chains to get creative
again. But the current promotion bears little resemblance to the event that, apparently eons ago, ushered in the Christmas selling season by offering shoppers, for a limited time on the day following Thanksgiving, holiday specials that lured customers into all manner of stores.
Walgreens-Rite Aid deal changes game
The spectacular is becoming so commonplace that even the most astonishing events in chain drug retailing are assuming a ho-hum characteristic. Nothing new here, even if Walgreens has announced its intention to acquire Rite Aid.
Pessina motivates WBA to reach for more
Stefano Pessina is once again changing the face of community pharmacy.
Health care partnerships are wave of the future
The move toward closer cooperation among providers is one of the more intriguing developments in health care, one that promises to improve patient outcomes and limit expenditures in a sector that accounts for almost 20% of the nation’s gross domestic product.
Walmart understands times are changing
and the rub-off impacted the entire retail community. Indeed,
Social media has impact on consumer health care
There are many social media channels, and personal experiences with them vary based on age, interests, technology savvy and more. Depending on one’s interests or information being sought, there are likely a variety of ways to participate or find others online that can relate.
Rx makers should work to reframe pricing debate
health care will be a prominent issue as the process of choosing Barack Obama’s successor
Coming year will be crucial for the industry
As the year 2015 winds down, the chain drug community must face the reality that the coming year will be unlike any that has preceded it. The same drug chains still rule the U.S. landscape. But the content of their character and the face of the people who guide them are vastly different than in